Research subjects must receive fair benefits
In this article, a group of more than 30 researchers from Africa and the United States complain that this guidance is too narrow, because it focuses only on the provision of knowledge and drugs.
They argue that communities involved in medical trials must determine whether they will receive a fair level of benefits, both during and after the research. These benefits could range from the provision of treatments for disease, to health care training, improved medical facilities, and employment opportunities.
Reference: Science 298, 5601 (2002)
Link to Science article